Feed Top Reports Pricing

⌘K

08:14:59·36d

INSIDERFiling

SEC Form 3 filed by Cellebrite DI Ltd.

CLBT· Cellebrite DI Ltd.

Technology

Full content unavailable. See the original source below.

Original source

Companies

CLBT
Cellebrite DI Ltd.
Technology

Recent analyst ratings

Mar 28UpdateNeedham$13.50
Mar 13UpdateWilliam Blair-
Feb 16UpdateBofA Securities$12.00
Jul 19UpdateCraig Hallum$11.00
Aug 12UpdateBofA Securities$6.00
Aug 12UpdateWilliam Blair-

Related

PR2d
Cellebrite to Report First-Quarter 2026 Financial Results on May 14, 2026
PR8d
Cellebrite Announces 20 JUSTYS Award Winners at C2C User Summit 2026
PR23d
Cellebrite Spring Release: New Industry-Leading Device Access and Multi-Cloud Expansion
INSIDER36d
SEC Form 3 filed by new insider Domnitz Yonatan
INSIDER36d
SEC Form 3 filed by new insider Utsumi Ryusuke
INSIDER36d
SEC Form 3 filed by Cellebrite DI Ltd.
INSIDER36d
SEC Form 3 filed by new insider Richardson Troy
INSIDER36d
SEC Form 3 filed by Cellebrite DI Ltd.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022